Skip to main content

Implant

1
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Peptide
2100%
+ 2 programs with unclassified modality

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Prevail Therapeutics
1 program
1
TeriparatidePhase 2Peptide
Advanced Bionics
Advanced BionicsCA - Valencia
2 programs
ClearVoiceN/A1 trial
Sound Processing Strategy - ClearVoiceN/A
Active Trials
NCT01066780Completed48Est. Sep 2010
Eli Lilly and Company
Eli Lilly and CompanyINDIANAPOLIS, IN
1 program
TeriparatidePHASE_2Peptide1 trial
Active Trials
NCT01279187Terminated27Est. Nov 2015

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Eli Lilly and CompanyTeriparatide
Advanced BionicsClearVoice

Clinical Trials (2)

Total enrollment: 75 patients across 2 trials

The Impact of Parathyroid Hormone (PTH) on Craniofacial Osseous Regeneration in Bone

Start: Feb 2011Est. completion: Nov 201527 patients
Phase 2Terminated

ClearVoice Sound-processing Strategy for AB HiRes 120 Cochlear Implant Users

Start: Mar 2010Est. completion: Sep 201048 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.